Mixed methods evaluation of workshops for citizen health advocates about financial conflicts of interests in healthcare.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
10 05 2020
Historique:
entrez: 13 5 2020
pubmed: 13 5 2020
medline: 31 3 2021
Statut: epublish

Résumé

To evaluate workshops delivered to citizen health advocates about financial conflicts of interest in healthcare, transparency databases which disclose industry payments in the USA and Australia and the pros and cons of advocacy groups accepting industry sponsorship. Thematic analysis of workshop participant recorded discussions, and pre, post and 3-month follow-up questionnaires on confidence and knowledge about financial conflicts of interest, transparency databases and the merits of advocacy organisations accepting industry sponsorship. 48 citizen health advocates participated in a half-day workshop, held in four Australian cities, which ended with a 1-hour recorded discussion. Participants were recruited with assistance from leading state-based health advocacy organisations. The thematic analysis of the recorded discussions revealed two major themes, (i) transparency and (ii) relationships with industry; and three minor themes: a lack of awareness about conflicts of interest and transparency, issues relating to trust and next steps in terms of potential reforms. In relation to transparency, participants felt strong support for transparency, strongly favouring the mandatory, extensive and accessible US Open Payments over the self-regulatory Australian model. Participants also noted that transparency had limitations, including the utility of disclosed information. In relation to industry sponsorship of advocacy groups, some participants expressed an openness to and support for accepting sponsorship, while many expressed a caution around potential downsides. Questionnaire results showed increases in both confidence and knowledge after the workshop, though only 23 of 48 participants returned the 3-month follow-up questionnaire. Following a half-day workshop, citizen health advocates recruited by leading health advocacy organisations expressed strong support for tough transparency rules, and mixed feelings about advocacy groups accepting sponsorship from industry. Study limitations include a non-representative sample and a large drop-out at the 3-month post-workshop follow-up.

Identifiants

pubmed: 32393611
pii: bmjopen-2019-034195
doi: 10.1136/bmjopen-2019-034195
pmc: PMC7223283
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e034195

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

JAMA Intern Med. 2017 Mar 1;177(3):344-350
pubmed: 28114624
PLoS Med. 2013 Aug;10(8):e1001500
pubmed: 23966841
Pain Med. 2016 Feb;17(2):218-9
pubmed: 26814303
JAMA Intern Med. 2016 Aug 1;176(8):1114-1122
pubmed: 27322350
Account Res. 2013;20(2):127-41
pubmed: 23432773
Cochrane Database Syst Rev. 2017 Feb 16;2:MR000033
pubmed: 28207928
BMJ. 2010 Mar 18;340:c1344
pubmed: 20299696
Health Expect. 2015 Apr;18(2):273-87
pubmed: 23252397
BMJ. 2019 Apr 16;365:l1706
pubmed: 30992258
BMJ Evid Based Med. 2019 Oct;24(5):170-173
pubmed: 30962252
BMJ Open. 2019 Feb 19;9(2):e024928
pubmed: 30782921
BMJ. 2019 Dec 3;367:l6576
pubmed: 31796508
PLoS One. 2017 Feb 3;12(2):e0170142
pubmed: 28158214
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
JAMA Intern Med. 2017 Mar 1;177(3):350-351
pubmed: 28114596

Auteurs

Ray Moynihan (R)

Institute for Evidence-Based Healthcare, Bond University, Gold Coast, Queensland, Australia raymoynihan@bond.edu.au.

Alice Fabbri (A)

Charles Perkins Centre and School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

Lisa Parker (L)

Centre for Values, Ethics and the Law in Medicine, University of Sydney, Sydney, New South Wales, Australia.

Lisa Bero (L)

Charles Perkins Centre and School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH